Editas Medicine, Inc.
EDITNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $291.08M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.66$4.33
- Volume (live)
- -
- Avg. volume (3M)
- 2.99M
Editas Medicine (EDIT) Stock Price & Financial Analysis
Editas Medicine Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.25 - $2.47 |
|---|---|
| 52-Week High | $4.33 |
| 52-Week Low | $1.66 |
| Open | $2.26 |
| Volume (last close) | 1.86M |
| Average Volume (3M) | 2.99M |
| Revenue (TTM) | 47.01M |
|---|---|
| Net Income (TTM) | -73.95M |
| Free Cash Flow (TTM) | -120.55M |
| EPS (TTM) | −$0.75 |
| Profit Margin | -157.32% |
| Operating Margin | -177.56% |
| Return on Equity (ROE) | -70.24% |
| Debt to Equity | 0.15 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 291.08M |
|---|---|
| Shares Outstanding | 119.29M |
| Price to Sales (P/S) | 6.19 |
| Price to Book (P/B) | 2.76 |
| EV/EBITDA | -1.78 |
| 50-Day MA | $2.84 |
|---|---|
| 200-Day MA | $2.65 |
| 1-Year Change | −38.38% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Editas Medicine at a Glance
As of the Oct 15, 2026 close, Editas Medicine (EDIT) has a market capitalization of $291.08M. The stock trades at 6.2× sales. Over the trailing twelve months it lost $73.95M on revenue of $47.01M and burned $120.55M of free cash flow. Revenue grew 20.8% year over year.
As of its latest reported balance sheet, it holds $181.81M in cash and securities against $15.51M of debt, a net cash position of $166.30M.
Editas Medicine does not currently pay a dividend.
The share price is down 38.4% over the past year. At $2.44 (the Oct 15, 2026 close) it sits within its 52-week range of $1.66 to $4.33, below its 200-day moving average of $2.65.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $5.67, 132.4% above the Oct 15, 2026 close.
Frequently Asked Questions About Editas Medicine
What is the current stock price for EDIT?
As of the Oct 15, 2026 close, EDIT stock trades at $2.44. The 52-week range is $1.66–$4.33, with a day range of $2.25–$2.46.
What is the P/E ratio for EDIT?
The P/E ratio (Price-to-Earnings) for EDIT is shown in the Key Statistics section. This valuation metric helps compare Editas Medicine, Inc. to industry peers.
Does EDIT pay dividends?
Editas Medicine does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for EDIT?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for EDIT is Buy. The average 12-month price target is $5.67, a 132.4% upside from the Oct 15, 2026 close of $2.44.
What is the market cap of EDIT?
As of the Oct 15, 2026 close, Editas Medicine's market capitalization is $291.1M, classifying it as a micro-cap company. Editas Medicine operates in the Healthcare sector within the Biotechnology industry.